tetano
Editor, Senior Moderator
Infect Genet Evol
. 2022 Sep 4;105360.
doi: 10.1016/j.meegid.2022.105360. Online ahead of print.
A 21L/BA.2-21K/BA.1 "MixOmicron" SARS-CoV-2 hybrid undetected by qPCR that screen for variant in routine diagnosis
Philippe Colson[SUP] 1 [/SUP], Jeremy Delerce[SUP] 2 [/SUP], Elise Marion-Paris[SUP] 3 [/SUP], Jean-Christophe Lagier[SUP] 4 [/SUP], Anthony Levasseur[SUP] 5 [/SUP], Pierre-Edouard Fournier[SUP] 6 [/SUP], Bernard La Scola[SUP] 4 [/SUP], Didier Raoult[SUP] 5 [/SUP]
Affiliations
Abstract
Among the multiple SARS-CoV-2 variants identified since summer 2020, several have co-circulated, creating opportunities for coinfections and potentially genetic recombinations that are common in coronaviruses. Viral recombinants are indeed beginning to be reported more frequently. Here, we describe a new SARS-CoV-2 recombinant genome that is mostly that of a Omicron 21L/BA.2 variant but with a 3' tip originating from a Omicron 21K/BA.1 variant. Two such genomes were obtained in our institute from adults sampled in February 2022 in university hospitals of Marseille, southern France, by next-generation sequencing carried out with the Illumina or Nanopore technologies. The recombination site was located between nucleotides 26,858-27,382. In the two genomic assemblies, mean sequencing depth at mutation-harboring positions was 271 and 1362 reads and mean prevalence of the majoritary nucleotide was 99.3 ± 2.2% and 98.8 ± 1.6%, respectively. Phylogeny generated trees with slightly different topologies according to whether genomes were depleted or not of the 3' tip. This 3' terminal end brought in the Omicron 21L/BA.2 genome a short transposable element of 41 nucleotides named S2m that is present in most SARS-CoV-2 except a few variants among which the Omicron 21L/BA.2 variant and may be involved in virulence. Importantly, this recombinant is not detected by currently used qPCR that screen for variants in routine diagnosis. The present observation emphasizes the need to survey closely the genetic pathways of SARS-CoV-2 variability by whole genome sequencing, and it could contribute to gain a better understanding of factors that lead to observed differences between epidemic potentials of the different variants.
Keywords: 21K/BA.1; 21L/BA.2; Epidemic; Lineage; Omicron; Recombinant; SARS-CoV-2; Variant.
. 2022 Sep 4;105360.
doi: 10.1016/j.meegid.2022.105360. Online ahead of print.
A 21L/BA.2-21K/BA.1 "MixOmicron" SARS-CoV-2 hybrid undetected by qPCR that screen for variant in routine diagnosis
Philippe Colson[SUP] 1 [/SUP], Jeremy Delerce[SUP] 2 [/SUP], Elise Marion-Paris[SUP] 3 [/SUP], Jean-Christophe Lagier[SUP] 4 [/SUP], Anthony Levasseur[SUP] 5 [/SUP], Pierre-Edouard Fournier[SUP] 6 [/SUP], Bernard La Scola[SUP] 4 [/SUP], Didier Raoult[SUP] 5 [/SUP]
Affiliations
- PMID: 36070806
- DOI: 10.1016/j.meegid.2022.105360
Abstract
Among the multiple SARS-CoV-2 variants identified since summer 2020, several have co-circulated, creating opportunities for coinfections and potentially genetic recombinations that are common in coronaviruses. Viral recombinants are indeed beginning to be reported more frequently. Here, we describe a new SARS-CoV-2 recombinant genome that is mostly that of a Omicron 21L/BA.2 variant but with a 3' tip originating from a Omicron 21K/BA.1 variant. Two such genomes were obtained in our institute from adults sampled in February 2022 in university hospitals of Marseille, southern France, by next-generation sequencing carried out with the Illumina or Nanopore technologies. The recombination site was located between nucleotides 26,858-27,382. In the two genomic assemblies, mean sequencing depth at mutation-harboring positions was 271 and 1362 reads and mean prevalence of the majoritary nucleotide was 99.3 ± 2.2% and 98.8 ± 1.6%, respectively. Phylogeny generated trees with slightly different topologies according to whether genomes were depleted or not of the 3' tip. This 3' terminal end brought in the Omicron 21L/BA.2 genome a short transposable element of 41 nucleotides named S2m that is present in most SARS-CoV-2 except a few variants among which the Omicron 21L/BA.2 variant and may be involved in virulence. Importantly, this recombinant is not detected by currently used qPCR that screen for variants in routine diagnosis. The present observation emphasizes the need to survey closely the genetic pathways of SARS-CoV-2 variability by whole genome sequencing, and it could contribute to gain a better understanding of factors that lead to observed differences between epidemic potentials of the different variants.
Keywords: 21K/BA.1; 21L/BA.2; Epidemic; Lineage; Omicron; Recombinant; SARS-CoV-2; Variant.